Get the Stockscreener App
0.7102
0.75%
0.0053
Envveno Medical Corporation stock is traded at $0.7102, with a volume of 152.17K.
It is up +0.75% in the last 24 hours and down -26.63% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$0.7049
Open:
$0.72
24h Volume:
152.17K
Relative Volume:
0.16
Market Cap:
$13.69M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-0.3303
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
-1.37%
1M Performance:
-26.63%
6M Performance:
-79.99%
1Y Performance:
-78.80%
1-Day Range:
$0.7102
$0.7419
1-Week Range:
$0.6198
$0.7499
52-Week Range:
$0.6198
$5.62
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
0.7114 | 14.25M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
123.83 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.95 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
359.49 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.81 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.01 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Envveno Medical Corporation Stock (NVNO) Latest News
Can enVVeno Medical Corporation stock maintain growth trajectoryJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Why analysts maintain buy rating on enVVeno Medical Corporation (5HJ) stockBear Alert & Safe Entry Point Identification - newser.com
Published on: 2025-11-03 07:21:33 - newser.com
Will enVVeno Medical Corporation (5HJ) stock profit from fiscal stimulusOptions Play & Community Driven Trade Alerts - newser.com
Price momentum metrics for enVVeno Medical Corporation explained2025 Volatility Report & Stock Portfolio Risk Control - newser.com
enVVeno Medical Corporation stock prediction for this weekJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com
What Wall Street predicts for enVVeno Medical Corporation stock priceTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Visualizing enVVeno Medical Corporation stock with heatmaps2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
How to use a screener to detect enVVeno Medical Corporation breakouts2025 Biggest Moves & Verified Entry Point Detection - newser.com
Tools to monitor enVVeno Medical Corporation recovery probabilityJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
Can enVVeno Medical Corporation stock deliver strong Q4 earningsMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
enVVeno Medical Corporation stock trend forecast2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
Can enVVeno Medical Corporation stock sustain market leadershipWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Will enVVeno Medical Corporation (5HJ) stock benefit from Fed rate cuts2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com
Quantitative breakdown of enVVeno Medical Corporation recent move2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
enVVeno Medical Launches $50M Equity Offering Program - The Globe and Mail
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year - MSN
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance
NVNO: Financial Stability as FDA Discussions Progress - GuruFocus
enVVeno Medical (NASDAQ: NVNO) funds operations through Q2 2027; cash $31.0M - Stock Titan
Will enVVeno Medical Corporation (5HJ) stock justify high valuationWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Comparing enVVeno Medical Corporation in custom built stock radarsJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
enVVeno Medical sets up at-the-market offering up to $50M - Stock Titan
NVNO launches $50M at-the-market stock program with Ladenburg - Stock Titan
What drives enVVeno Medical Corporation 5HJ stock priceMonthly Performance Summary & Superior Trading Ideas - earlytimes.in
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):